We now report a case of acute cerebral infarction due to Trousseau syndrome in a patient who was recently diagnosed with lung cancer positive for an activating EGFR mutation and who was subsequently treated safely with the EGFR-TKIs gefitinib and osimertinib. The gene discussed is EGFR; the disease is lung cancer.